Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Change in Receivables (2020 - 2025)

Historic Change in Receivables for Whitehawk Therapeutics (WHWK) over the last 5 years, with Q1 2025 value amounting to $1.0 million.

  • Whitehawk Therapeutics' Change in Receivables rose 28018.02% to $1.0 million in Q1 2025 from the same period last year, while for Sep 2025 it was $363000.0, marking a year-over-year decrease of 5589.31%. This contributed to the annual value of $415000.0 for FY2024, which is 8855.49% down from last year.
  • According to the latest figures from Q1 2025, Whitehawk Therapeutics' Change in Receivables is $1.0 million, which was up 28018.02% from -$637000.0 recorded in Q4 2024.
  • Whitehawk Therapeutics' 5-year Change in Receivables high stood at $3.7 million for Q1 2023, and its period low was -$14.0 million during Q1 2021.
  • Over the past 5 years, Whitehawk Therapeutics' median Change in Receivables value was -$120000.0 (recorded in 2021), while the average stood at -$483066.7.
  • As far as peak fluctuations go, Whitehawk Therapeutics' Change in Receivables plummeted by 43750.0% in 2022, and later skyrocketed by 93080.81% in 2023.
  • Whitehawk Therapeutics' Change in Receivables (Quarter) stood at -$120000.0 in 2021, then plummeted by 232.5% to -$399000.0 in 2022, then surged by 42.61% to -$229000.0 in 2023, then crashed by 178.17% to -$637000.0 in 2024, then skyrocketed by 256.99% to $1.0 million in 2025.
  • Its Change in Receivables stands at $1.0 million for Q1 2025, versus -$637000.0 for Q4 2024 and $620000.0 for Q3 2024.